Paramount Club
New York, NY
LaunchBio’s NextGen VC Forum is the premiere event for mid-level venture capital associates to expand their skills and expertise while growing their network. Attendees benefit from curated education sessions from industry leaders to supplement existing expertise. Networking is essential in sourcing deals and one of the primary roles for associates, we’ve built it into the program for participants to be able to walk away with new life science and biotech contacts. The half-day forum created with Wilson Sonsini includes a networking lunch, three one-hour sessions, and a happy hour.
Attendance at NextGen VC Forum is by invitation only; if interested, please contact your firm’s senior partners.
Agenda
12:00 pm Arrival/check-in/light lunch/networking
12:45 pm Welcome and Introduction - Dan Koeppen and Mike Hostetler
1:00 pm Session 1: Investment Firm / Executive Compensation – Jody Thelander, Matthew Norgard, and Jim Jensen
2:15 pm Session 2: Navigating Antitrust Regulations - Brendan Coffman and Michelle Yost Hale
3:00 pm Break/snacks
4:00 pm Session 3: Company Creation - Phil McGill and Deborah Smith
5:00 pm Happy Hour and networking hosted by Wilson Sonsini
Alison Cornfeldt
acornfeldt@wsgr.comBased in the SOMA and San Diego offices, Mike Hostetler provides strategic IP counseling to growth enterprises in the pharmaceutical and biotechnology, and information technology industries.
Dan Koeppen is a corporate and securities partner in the firm's San Diego office. Dan specializes in corporate governance, mergers and acquisitions, public offerings, and venture capital financings. He has extensive experience representing public and private life science and technology companies in a wide range of sectors, including biotechnology, consumer products, data security, medical device, pharmaceutical, semiconductor, software, and social media, through all stages of their growth from start-up to mature public companies. In addition, Dan represents leading investment banks in their underwriting transactions, and regularly advises numerous venture capital firms and corporate strategic investors in connection with their investments in emerging growth companies.
Matthew Norgard is a partner-elect in the New York office of Wilson Sonsini Goodrich & Rosati, where he practices employee benefits and compensation law, focusing on the representation of private and public high technology and growth companies. As part of his practice, Matthew advises U.S. and international clients on the design, drafting, and administration of equity-based compensation programs (including stock option, restricted stock, and other equity arrangements); employment, consulting, retention, severance, change in control, and deferred compensation arrangements; and the associated tax (including Section 409A), accounting, ERISA, and securities law implications.
Michelle Hale is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on representing companies in government antitrust investigations, including mergers and acquisitions and other civil antitrust investigations. She regularly appears before the Federal Trade Commission (FTC) and the U.S. Department of Justice, representing companies across a range of industries. Michelle also provides antitrust counseling on a wide variety of business conduct, including joint ventures, collaborations, and pricing and distribution, among others.
Brendan Coffman is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the antitrust and competition practice. Brendan represents the world's most innovative companies in connection with mergers and acquisitions, joint ventures, government investigations, private litigation, and distribution practices. His clients include stalwarts and emerging firms in electronic gaming and entertainment, ridesharing and ADAS/Autonomous Driving, semiconductor and connectivity, pharmaceutical, healthcare, and financial services. Representative matters include the following:
Phillip (Phil) McGill is a partner-elect in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he represents clients on corporate and securities law matters in the life sciences and technology sectors. His practice is focused on being a strategic partner to companies throughout each phase of the corporate life cycle, with an emphasis on guiding companies through late-stage financings and exits, as well as post-IPO public company representation. He has particular expertise collaborating with venture capital firms and universities as counsel to companies formed through their discovery engine and incubator programs.
Deborah Smith is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. She assists with the preparation and prosecution of patent applications in the fields of chemistry, pharmaceuticals, and biotechnology.
Jim has nearly two decades of legal experience and has supported more than 250 investment and exit transactions in his career.